Manas AI
The AI-Native Biopharmaceutical Company
New York, United States · Founded 2025 · $50.6M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- manasai.co
- Total Funding
- $50.6M
- Last Round
- $26.0M Extension RoundSep 2025
- Rounds
- 2
About
AI-native biopharmaceutical company using neuro-symbolic models to accelerate drug discovery for oncology and other diseases.
Summary
Manas AI is a Life Sciences company based in New York, United States, founded in 2025. It has raised $50.6M in total across 2 rounds, most recently a $26.0M Extension Round round in Sep 2025. Investors include The General Partnership, General Catalyst and Blitzscaling Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...